In an effort to address ongoing transmission of leprosy, our Leprosy Post-Exposure Prophylaxis (LPEP) program provides preventative treatment to close contacts of newly diagnosed patients – such as family members or friends – among whom are those most at risk.
LPEP is implemented to answer key questions of contact tracing and administration of preventative treatment, feasibility and impact across various healthcare systems in Asia, Africa and South America. Launched in 2014, LPEP is now operational in Brazil, Cambodia, India, Indonesia, Nepal, Myanmar, Tanzania and Sri Lanka.
LPEP is now included in the Operational Manual in the revised World Health Organization (WHO) Global Leprosy Strategy for 2016–2020.
Our LPEP partners include several International Federation of Anti-Leprosy Associations (ILEP) members: Netherlands Leprosy Relief, FAIRMED, American Leprosy Missions and the German Leprosy and TB Relief Association, as well as academic institutions including the Erasmus University Medical Center and the Swiss Tropical and Public Health Institute.